Search
+
    SEARCHED FOR:

    US DEBT CEILING DEAL

    Goldman Sachs posts strong Q2 profits on debt underwriting and fixed-income trading surge

    Goldman Sachs' profit more than doubled in the second quarter, bolstered by higher fees from debt underwriting and a strong performance in its fixed-income trading business.

    Ahead of budget, US-India forum urges FM Sitharaman for stable & predictable tax environment

    The US-India Strategic Partnership Forum (USISPF) has urged Union Finance Minister Nirmala Sitharaman to prioritize a stable and predictable tax environment in the upcoming Union Budget 2024-25. Emphasizing the need for measures that stimulate growth across sectors, the US-India Tax Forum, a part of USISPF, recommended enhancing ease of doing business, rationalizing business costs, and simplifying tax rates.

    Biocon Biologics to raise debt of Rs 4,500 crore for Viatris Payout

    Biocon Biologics plans to raise ₹4,500 crore with HSBC and MUFG's aid for a $175 million Aflibercept option. Previous funding by Kotak and Edelweiss and Crisil predicts ₹4,800 crore debt by FY26. Tackling $1.2 billion debt, Biocon's net profit at 7% due to high-interest costs. Revenue at 57% in FY24. Ownership stands at 70%, market improved post-Viatris transition.

    ONGC Videsh to raise USD 800 million from 3 banks

    The pricing of the loan could change depending on the level of interest from other participating banks, a second person said. At 120 basis points above the three-month SOFR rate, which is currently trading at about 5.30%, the loan could be priced at about 6.50%. One basis point is 0.01 percentage point.

    Promoter selling can cross Rs 1 lakh crore mark as retail investors buy using MFs

    With retail investors continuing to be on a buying spree using the mutual fund route, the trend of stake sale by promoters in NSE500 companies looks on track to cross the Rs 1 lakh crore mark.

    US fund Platinum acquires Inventia Health in India foray

    Platinum Equity makes its debut in India by acquiring a majority stake in Mumbai's Inventia Healthcare. With a valuation of Rs 2,500 crore, the deal sees PE investors exiting while the promoter retains a minority stake. Platinum Equity, managing over $48 billion in assets, is well-known for its expertise in the healthcare sector.

    The Economic Times
    BACK TO TOP